Form 4: Clorox EVP Acquires 7,048 Shares in RSU Grant

Clorox's EVP and Chief Legal Officer, Angela C. Hilt, acquired 7,048 shares of common stock through a restricted stock unit grant on September 16, 2025.

Summary

• Angela C. Hilt, Executive Vice President and Chief Legal Officer of The Clorox Company (CLX), acquired 7,048 shares of common stock.
• The transaction occurred on September 16, 2025, with the shares acquired at a price of $124.85 per share.
• These shares were granted as Restricted Stock Units (RSUs) and are subject to a vesting schedule.
• The RSUs will vest in four equal installments, with 25% vesting on October 5, 2026, 2027, 2028, and 2029, respectively.
• Following this acquisition, Ms. Hilt directly beneficially owns 26,881 shares of common stock.
• Additionally, Ms. Hilt indirectly beneficially owns 609.663 shares through the company's 401(k) plan, including shares acquired through September 16, 2025.
• The total value of the acquired RSU grant is approximately $879,995.80.

Sentiment

Score: 7

Explanation: The filing indicates a routine executive compensation event (RSU grant), which is generally positive as it aligns management's interests with shareholders. It does not suggest any negative operational or financial issues.

Positives

• The acquisition of shares through a Restricted Stock Unit grant increases executive ownership, aligning management's interests with those of shareholders.
• The grant serves as an incentive for executive retention and performance, reinforcing long-term commitment to the company's success.

Future Outlook

The Restricted Stock Units are scheduled to vest in four annual installments from October 2026 through October 2029, indicating a long-term incentive structure for the executive.

Industry Context

This transaction represents a routine executive compensation event, common across publicly traded companies to incentivize and retain key management personnel by aligning their financial interests with long-term shareholder value. It does not reflect a unique industry trend but rather a standard corporate governance practice.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of executive compensation is a widely adopted practice across various industries, including consumer goods, aligning with global benchmarks for executive incentive programs.
• The vesting schedule, spread over four years, is typical for long-term incentive plans, comparable to practices at peer companies in the consumer staples sector such as Procter & Gamble (PG) or Kimberly-Clark (KMB), which also utilize multi-year vesting for equity awards to promote sustained performance and retention.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value through equity ownership.
• Employees: Reinforces the company's commitment to executive retention and performance-based incentives.

Next Steps

• The Restricted Stock Units will vest in four equal installments on October 5, 2026, October 5, 2027, October 5, 2028, and October 5, 2029.

Key Dates

Recommendation

This filing details a routine Restricted Stock Unit grant to an executive, which is a standard component of compensation. While positive for management alignment, it does not present new information that would fundamentally alter the investment thesis or warrant a change in stock recommendation for a seasoned investor or institution.

Keywords

Clorox, CLX, Insider Transaction, Form 4, Restricted Stock Units, RSU, Executive Compensation, Stock Acquisition